News Briefing channel feed – Endpoints News

News Briefing channel feed

Biotech receives award from DOD; Regulators accept Appili Therapeutics' NDA

3 years ago

Aldeyra’s sights set on November PDUFA; Synbio startup scores cash

3 years ago

AbbVie opens up to bigger deals as competition heats up — report; Small radiopharmaceutical player goes public via reverse merger

3 years ago

Eisai cutting 91 jobs after out-license deal; Merck touts first-line Keytruda results in endometrial cancer

3 years ago

Tonix snaps up assets from Healion Bio; Mesoblast gives its BLA another shot

3 years ago

GreenLight's mRNA vaccine nabs trial OK; Ratio reels in radiotherapy funds

3 years ago

Sensorion partners on injection system for therapy delivery; Kymera and X-Chem expand deal

3 years ago

Pfizer invests in Ribon Therapeutics; Argenx gets PDUFA date extension

3 years ago

Evotec inks license agreement with J&J; Oncolytic virus biotech prices $15M IPO

3 years ago

FDA adcomm votes in favor of new antifungal; Denali gets $25M from Sanofi MS trial milestone

3 years ago

Iovance picks up IL-2 Proleukin for $200M+ upfront; Estrella Biopharma to wait for SPAC deal finish

3 years ago

Seagen's Tukysa label expanded; ADARx gets $46M script for RNA trial

3 years ago

Caris gets $400M loan from OrbiMed and Braidwell; bluebird stock sales brings in $120M

3 years ago

Aeterna discontinues vaccine development; Idera rebrands as Aceragen

3 years ago

FDA puts Vertex’s new Type 1 diabetes cell therapy IND on hold; Insilico sets up for PhII of AI drug

3 years ago

FDA accepts one, delays another; Data, deals and dollars for slate of biotechs

3 years ago

Three biotechs start the year with job cuts; Regeneron expands deal with bluebird spinout

3 years ago

Y-mAbs cuts 35% of staff; Genentech re-ups Nimble deal; Landos shifts focus; and more

3 years ago

Jasper Therapeutics sees a stock boost after sickle cell data release; Newron lifts the veil on data for schizophrenia treatment

3 years ago

News wrap: Equillium axes Metacrine merger; Two pharmas pen ADC deals

3 years ago

SPAC extends deadline to merge — again; Flagship's Evelo borrows $45M to refinance debt

3 years ago

Novavax plans to raise $250M through stock, debt sales; Penny stock company plans reverse merger

3 years ago

Boehringer Ingelheim buys CD38 drug; Merck bets on machine learning in antibody design

3 years ago

Prothena nets more cash from Novo Nordisk; Khondrion fails to hit endpoint

3 years ago

First page Previous page 18 19 202122 23 24 Next page Last page